Design and baseline participant characteristics of the human immunodeficiency virus Epidemiology Research (HER) study: A prospective cohort study of human immunodeficiency virus infection in US women

American Journal of Epidemiology

Volumn 146, Issue 6, 1997, Pages 459-469

  Smith, Dawn K ^a   Warren, Dora L ^b   Vlahov, David ^c   Schuman, Paula ^d   Stein, Michael D ^e   Greenberg, Barbara L ^f   Holmberg, Scott D ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Brown University AIDS Program   (United States)

^f MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Acquired immunodeficiency syndrome; Cohort studies; Disease progression; HIV; Women

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; COHORT ANALYSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; PATIENT SELECTION; PHYSICAL EXAMINATION; PROGNOSIS; UNITED STATES;

EID: 0030794925     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009299     Document Type: Article

References (31)

1. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. No. 2. Atlanta, GA: Centers for Disease Control and Prevention, 1995;7:1-39.
2. Centers for Disease Control. Acquired immunodeficiency syndrome (AIDS) update - United States. MMWR 1983;32: 309-11.
3. Cotton DJ, Finkelstein DM, He W, et al. Determinants of accrual of women to a large, multicenter clinical trials program of human immunodeficiency virus infection. The AIDS Clinical Trials Group. J Acquir Immune Defic Syndr Hum Retrovirol 1993;6:1322-8.
4. American Academy of Neurology AIDS Task Force. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type I (HIV-1) infection. Neurology 1991;41:778-85.
5. Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. J Appl Psychol Meas 1977;1:385-401.
6. Cu-Uvin S, Warren D, Mayer K, et al. Prevalence of genital tract infections in HIV infected women. Abstract no. FC1-178. In: Abstract book, HIV Infection in Women Conference, Washington, DC, February 22-24, 1995. Richmond, VA: Philadelphia Sciences Group, 1995:S51.
7. Schuman P, Sobel JD, Mayer K, et al. Candida colonization in women at risk for HIV infection. Abstract no. FC1-176. In: Abstract book, HIV Infection in Women Conference, Washington, DC, February 22-24, 1995. Richmond, VA: Philadelphia Sciences Group, 1995:S50.
8. Schuman P, Greene V, Klein RS, et al. Oral lesions in women at risk for HIV infection. Abstract no. 584. In: Abstract book, Second National Conference on Human Retroviruses and Related Infections, Washington, DC, January 29-February 2, 1995. Washington, DC: American Society for Microbiology, 1995:162.
9. Flanigan TP, Mayer K, Smith D, et al. Self-reported bacterial infections in HIV+ and high-risk HIV-women. Abstract no. WP-421. In: Abstract book, HIV Infection in Women Conference, Washington, DC, February 22-24, 1995. Richmond, VA: Philadelphia Sciences Group, 1995:P60.
10. Smith DK, Schoenbaum EE, Peipert J, et al. Prevalence of bacteriuria among HIV+ and HIV-women. Abstract no. FC1-179. In: Abstract book, HIV Infection in Women Conference, Washington, DC, February 22-24, 1995. Richmond, VA: Philadelphia Sciences Group, 1995:S51.
11. Klein RS, Flanigan R, Vlahov D, et al. Cutaneous anergy in women at risk for HIV infection. Abstract no. 583. In: Abstract book, Second National Conference on Human Retroviruses and Related Infections, Washington, DC, January 29-February 2, 1995. Washington, DC: American Society for Microbiology, 1995:162.
12. Klein RS, Shah K, Cu-Uvin S, et al. Genital human papillomavirus (HPV) infection and squamous intraepithelial lesions (SIL) on Pap smear in women at risk for HIV infection. Abstract no. 195. In: Abstract book, Second National Conference on Human Retroviruses and Related Infections, Washington, DC, January 29-February 2, 1995. Washington, DC: American Society for Microbiology, 1995:90.
13. Burk RD, Tachezy R, Daniels R, et al. Interlaboratory comparison of HPV DNA detection by PCR and correlation with Southern blot. Abstract no. 45. In: Abstracts of the 13th International Papillomavirus Conference, Amsterdam, the Netherlands, October 8-12, 1994.
14. Shah KV, Burk R, Klein R, et al. Prevalence of genital human papillomavirus (HPV) infections by two detection methods in women at risk for HIV. Abstract no. WP-366. In: Abstract book, HIV Infection in Women Conference, Washington, DC, February 22-24, 1995. Richmond, VA: Philadelphia Sciences Group, 1995:P82.
15. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991;29:297-301.
16. Warren D, Klein RS, Anderson J, et al. Bacterial vaginosis in women at risk for HIV infection. Abstract no. K96. In: Abstract book, vol. 1. 35th International Conference on Antimicrobial Agents and Chemotherapy, San Francisco, California, September 17-20, 1995. Washington, DC: American Society for Microbiology, 1955:304.
17. Vlahov D, Schoenbaum E, Smith D, et al. Clinical findings of HIV infected women by risk group. Abstract no. WP-396. In: Abstract book, HIV Infection in Women Conference, Washington, DC, February 22-24, 1995. Richmond, VA: Philadelphia Sciences Group, 1995.
18. Stein M, Schuman P, Solomon L, et al. Patterns of antiretroviral use among women in Providence and Wayne State. Abstract no. WP-309. In: Abstract book, HIV Infection in Women Conference, Washington, DC, February 22-24, 1995. Richmond, VA: Philadelphia Sciences Group, 1995:P68.
19. Solomon L, Stein M, Schoenbaum E, et al. Use of health care and antiretroviral medication among women in Baltimore and New York. Abstract no. WP-397. In: Abstract book, HIV Infection in Women Conference, Washington, DC, February 22-24, 1995. Richmond, VA: Philadelphia Sciences Group, 1995:P90.
20. Clark L, Schoenbaum E, Solomon L, et al. Concealment of HIV infection and psychological distress. In: Abstracts of the Annual Meeting of the American Psychological Association, Los Angeles, CA, August 12-16, 1994.
21. Moore J, Solomon L, Schoenbaum E, et al. Factors associated with stress and distress among HIV-infected and at-risk women. Abstract no. TA2-114. In: Abstract book, HIV Infection in Women Conference, Washington, DC, February 22-24, 1995. Richmond, VA: Philadelphia Sciences Group, 1995:S33.
22. Fiore TC, Lingle L, Flanigan TP, et al. HIV infection in the families of HIV positive women. Abstract no. WP-337. In: Abstract book, HIV Infection in Women Conference, Washington, DC, February 22-24, 1995. Richmond, VA: Philadelphia Sciences Group, 1995:P75.
23. Klein RS, Dubler N, DiStabile P, et al. Self-reported legal needs of women at risk for HIV infection. Abstract no. WP-335. In: Abstract Book, HIV Infection in Women Conference, Washington, DC, February 22-24, 1995. Richmond, VA: Philadelphia Sciences Group, 1995:P74.
24. Schoenbaum EE, Moore J, Schuman P, et al. Patterns of condom use in HIV infected and HIV uninfected women. Abstract no. WE3-79. In: Abstract book, HIV Infection in Women Conference, Washington, DC, February 22-24, 1995. Richmond, VA: Philadelphia Sciences Group, 1995:S22.
25. Zierler S, Stein M, Schoenbaum E, et al. Comparison of women's sexual activity according to HIV serostatus. Abstract no. FF1-192. In: Abstract book, HIV Infection in Women Conference, Washington, DC, February 22-24, 1995. Richmond VA: Philadelphia Sciences Group, 1995:S55.
26. Jaffe HW, Darrow WW, Echenberg DF, et al. The acquired immune deficiency syndrome in a cohort of homosexual men: a six-year follow-up study. Ann Intern Med 1985;103:210-14.
27. Piazza T. Sampling methods and wave 1 field results of the San Francisco Men's Health Study. Report to the National Institute of Allergy and Infectious Diseases 1986:1-23.
28. Kaslow RA, Ostrow DG, Detels R, et al. The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol 1987;126:310-18.
29. Selwyn PA, Alcabes P, Hartel D, et al. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N Engl J Med 1992;
30. Vlahov D, Anthony JC, Muñoz A, et al. The ALIVE Study: a longitudinal study of HIV-1 infection in intravenous drug users: description of methods. J Drug Issues 1991;21:759-76.
31. Diaz T, Chu SY, Sorvillo F, et al. Differences in participation in experimental drug trials among persons with AIDS. J Acquir Immune Defic Syndr 1995;10:562-8.